U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07564557) titled 'Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)' on April 12.
Brief Summary: The purpose of this study is to evaluate the safety and effectiveness of a specialized surgical technique called "Septum-guided Segmentectomy" for treating early-stage lung cancer located deep within the lung tissue.Standard surgery for lung cancer often involves removing an entire lung lobe (lobectomy), which can significantly reduce a patient's breathing capacity. For small tumors, removing only a segment of the lung (segmentectomy) can preserve more healthy tissue. However, for tumors located deep in the lung, traditional segmentecto...